Skip to main content
Erschienen in: Current Gastroenterology Reports 11/2013

01.11.2013 | Stomach and Duodenum (J Pisegna, Section Editor)

Management of Radiation-Induced Rectal Bleeding

verfasst von: Liboria Laterza, Paolo Cecinato, Alessandra Guido, Alessandro Mussetto, Lorenzo Fuccio

Erschienen in: Current Gastroenterology Reports | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Pelvic radiation disease is one of the major complication after radiotherapy for pelvic cancers. The most commonly reported symptom is rectal bleeding which affects patients’ quality of life. Therapeutic strategies for rectal bleeding are generally ignored and include medical, endoscopic, and hyperbaric oxygen treatments. Most cases of radiation-induced bleeding are mild and self-limiting, and treatment is normally not indicated. In cases of clinically significant bleeding (i.e. anaemia), medical therapies, including stool softeners, sucralfate enemas, and metronidazole, should be considered as first-line treatment options. In cases of failure, endoscopic therapy, mainly represented by argon plasma coagulation and hyperbaric oxygen treatments, are valid and complementary second-line treatment strategies. Although current treatment options are not always supported by high-quality studies, patients should be reassured that treatment options exist and success is achieved in most cases if the patient is referred to a dedicated centre.
Literatur
1.
Zurück zum Zitat Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.PubMedCrossRef Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.PubMedCrossRef
2.
Zurück zum Zitat Bazan JG, Hara W, Hsu A, et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011;117:3342–51.PubMedCrossRef Bazan JG, Hara W, Hsu A, et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011;117:3342–51.PubMedCrossRef
3.
Zurück zum Zitat Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–9.PubMedCrossRef Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–9.PubMedCrossRef
4.
Zurück zum Zitat Staffurth J. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2010;22:643–57.CrossRef Staffurth J. A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2010;22:643–57.CrossRef
5.
Zurück zum Zitat Hasselle MD, Rose BS, Kochanski JD, et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011;80:1436–45.PubMedCrossRef Hasselle MD, Rose BS, Kochanski JD, et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011;80:1436–45.PubMedCrossRef
6.
Zurück zum Zitat Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1438–44.PubMedCrossRef Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1438–44.PubMedCrossRef
7.
Zurück zum Zitat Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer. 1994;74:2520–32.PubMedCrossRef Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer. 1994;74:2520–32.PubMedCrossRef
8.
Zurück zum Zitat Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology. 1996;47:387–94.PubMedCrossRef Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology. 1996;47:387–94.PubMedCrossRef
9.
Zurück zum Zitat Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353:267–72.PubMedCrossRef Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet. 1999;353:267–72.PubMedCrossRef
10.
Zurück zum Zitat Putta S, Andreyev HJ. Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol). 2005;17:469–77.CrossRef Putta S, Andreyev HJ. Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol). 2005;17:469–77.CrossRef
11.
Zurück zum Zitat Johnston MJ, Robertson GM, Frizelle FA. Management of late complications of pelvic radiation in the rectum and anus: a review. Dis Colon Rectum. 2003;46:247–59.PubMedCrossRef Johnston MJ, Robertson GM, Frizelle FA. Management of late complications of pelvic radiation in the rectum and anus: a review. Dis Colon Rectum. 2003;46:247–59.PubMedCrossRef
12.
Zurück zum Zitat Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18:987–94.PubMedCrossRef Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18:987–94.PubMedCrossRef
13.
Zurück zum Zitat Fuccio L, Guido A, Laterza L, et al. Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer. Aliment Pharmacol Ther. 2011;34:628–37.PubMedCrossRef Fuccio L, Guido A, Laterza L, et al. Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer. Aliment Pharmacol Ther. 2011;34:628–37.PubMedCrossRef
14.
Zurück zum Zitat Goldner G, Potter R, Kranz A, et al. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy. Strahlenther Onkol. 2011;187:202–5.PubMedCrossRef Goldner G, Potter R, Kranz A, et al. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy. Strahlenther Onkol. 2011;187:202–5.PubMedCrossRef
15.
Zurück zum Zitat Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 1998;41:83–92.PubMedCrossRef Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 1998;41:83–92.PubMedCrossRef
16.
Zurück zum Zitat Chun M, Kang S, Kil HJ, et al. Rectal bleeding and its management after irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys. 2004;58:98–105.PubMedCrossRef Chun M, Kang S, Kil HJ, et al. Rectal bleeding and its management after irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys. 2004;58:98–105.PubMedCrossRef
17.
Zurück zum Zitat Denham JW, Hauer-Jensen M. The radiotherapeutic injury–a complex 'wound'. Radiother Oncol. 2002;63:129–45.PubMedCrossRef Denham JW, Hauer-Jensen M. The radiotherapeutic injury–a complex 'wound'. Radiother Oncol. 2002;63:129–45.PubMedCrossRef
18.
Zurück zum Zitat Brenn T, Fletcher CD. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006;48:106–14.PubMedCrossRef Brenn T, Fletcher CD. Postradiation vascular proliferations: an increasing problem. Histopathology. 2006;48:106–14.PubMedCrossRef
19.
Zurück zum Zitat Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–31.PubMedCrossRef Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–31.PubMedCrossRef
20.
Zurück zum Zitat Wedlake LJ, Thomas K, Lalji A, et al. Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys. 2010;78:1163–70.PubMedCrossRef Wedlake LJ, Thomas K, Lalji A, et al. Predicting late effects of pelvic radiotherapy: is there a better approach? Int J Radiat Oncol Biol Phys. 2010;78:1163–70.PubMedCrossRef
21.
22.
Zurück zum Zitat Bartoletti-Stella A, Mariani E, Kurelac I, et al. Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1alpha. Cell Death Dis. 2013;4:e663.PubMedCrossRef Bartoletti-Stella A, Mariani E, Kurelac I, et al. Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1alpha. Cell Death Dis. 2013;4:e663.PubMedCrossRef
23.
Zurück zum Zitat Resbeut M, Marteau P, Cowen D, et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol. 1997;44:59–63.PubMedCrossRef Resbeut M, Marteau P, Cowen D, et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol. 1997;44:59–63.PubMedCrossRef
24.
Zurück zum Zitat Baughan CA, Canney PA, Buchanan RB, et al. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol). 1993;5:19–24.CrossRef Baughan CA, Canney PA, Buchanan RB, et al. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol). 1993;5:19–24.CrossRef
25.
Zurück zum Zitat Kneebone A, Mameghan H, Bolin T, et al. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2004;60:1088–97.PubMedCrossRef Kneebone A, Mameghan H, Bolin T, et al. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2004;60:1088–97.PubMedCrossRef
26.
Zurück zum Zitat Stellamans K, Lievens Y, Lambin P, et al. Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial. Radiother Oncol. 2002;65:105–8.PubMedCrossRef Stellamans K, Lievens Y, Lambin P, et al. Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial. Radiother Oncol. 2002;65:105–8.PubMedCrossRef
27.
Zurück zum Zitat Sasse AD, Clark LG, Sasse EC, et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2006;64:784–91.PubMedCrossRef Sasse AD, Clark LG, Sasse EC, et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2006;64:784–91.PubMedCrossRef
28.
Zurück zum Zitat Kouloulias VE, Kouvaris JR, Pissakas G, et al. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys. 2005;62:486–93.PubMedCrossRef Kouloulias VE, Kouvaris JR, Pissakas G, et al. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys. 2005;62:486–93.PubMedCrossRef
29.
Zurück zum Zitat Zachariah B, Gwede CK, James J, et al. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst. 2010;102:547–56.PubMedCrossRef Zachariah B, Gwede CK, James J, et al. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst. 2010;102:547–56.PubMedCrossRef
30.
Zurück zum Zitat Fuccio L, Guido A, Eusebi LH, et al. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol. 2009;43:506–13.PubMedCrossRef Fuccio L, Guido A, Eusebi LH, et al. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol. 2009;43:506–13.PubMedCrossRef
31.
Zurück zum Zitat Fuccio L, Guido A, Andreyev HJ. Management of intestinal complications in patients with pelvic radiation disease. Clin Gastroenterol Hepatol. 2012;10:1326–1334 e4.PubMedCrossRef Fuccio L, Guido A, Andreyev HJ. Management of intestinal complications in patients with pelvic radiation disease. Clin Gastroenterol Hepatol. 2012;10:1326–1334 e4.PubMedCrossRef
32.
Zurück zum Zitat Henson CC, Andreyev HJ, Symonds RP, et al. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists. Clin Oncol (R Coll Radiol). 2011;23:552–7.CrossRef Henson CC, Andreyev HJ, Symonds RP, et al. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists. Clin Oncol (R Coll Radiol). 2011;23:552–7.CrossRef
33.
Zurück zum Zitat •• Andreyev HJ, Davidson SE, Gillespie C, et al. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61:179–92. The most recent practice guidance on the management of radiation-induced gastrointestinal adverse events. PubMedCrossRef •• Andreyev HJ, Davidson SE, Gillespie C, et al. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61:179–92. The most recent practice guidance on the management of radiation-induced gastrointestinal adverse events. PubMedCrossRef
34.
Zurück zum Zitat Cavcic J, Turcic J, Martinac P, et al. Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croat Med J. 2000;41:314–8.PubMed Cavcic J, Turcic J, Martinac P, et al. Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croat Med J. 2000;41:314–8.PubMed
35.
Zurück zum Zitat Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36:103–7.PubMedCrossRef Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36:103–7.PubMedCrossRef
36.
Zurück zum Zitat Vernia P, Fracasso PL, Casale V, et al. Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet. 2000;356:1232–5.PubMedCrossRef Vernia P, Fracasso PL, Casale V, et al. Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet. 2000;356:1232–5.PubMedCrossRef
37.
Zurück zum Zitat Talley NA, Chen F, King D, et al. Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis Colon Rectum. 1997;40:1046–50.PubMedCrossRef Talley NA, Chen F, King D, et al. Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis Colon Rectum. 1997;40:1046–50.PubMedCrossRef
38.
Zurück zum Zitat Pinto A, Fidalgo P, Cravo M, et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum. 1999;42:788–95. discussion 795-6.PubMedCrossRef Pinto A, Fidalgo P, Cravo M, et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum. 1999;42:788–95. discussion 795-6.PubMedCrossRef
39.
Zurück zum Zitat Hanson B, MacDonald R, Shaukat A. Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review. Dis Colon Rectum. 2012;55:1081–95.PubMedCrossRef Hanson B, MacDonald R, Shaukat A. Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review. Dis Colon Rectum. 2012;55:1081–95.PubMedCrossRef
40.
Zurück zum Zitat Postgate A, Saunders B, Tjandra J, et al. Argon plasma coagulation in chronic radiation proctitis. Endoscopy. 2007;39:361–5.PubMedCrossRef Postgate A, Saunders B, Tjandra J, et al. Argon plasma coagulation in chronic radiation proctitis. Endoscopy. 2007;39:361–5.PubMedCrossRef
41.
Zurück zum Zitat Kaassis M, Oberti E, Burtin P, et al. Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy. 2000;32:673–6.PubMedCrossRef Kaassis M, Oberti E, Burtin P, et al. Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy. 2000;32:673–6.PubMedCrossRef
42.
Zurück zum Zitat Morrow JB, Dumot JA, Vargo 2nd JJ. Radiation-induced hemorrhagic carditis treated with argon plasma coagulator. Gastrointest Endosc. 2000;51:498–9.PubMedCrossRef Morrow JB, Dumot JA, Vargo 2nd JJ. Radiation-induced hemorrhagic carditis treated with argon plasma coagulator. Gastrointest Endosc. 2000;51:498–9.PubMedCrossRef
43.
Zurück zum Zitat Gheorghe C, Gheorghe L, Iacob R, et al. Argon plasma coagulation for radiation proctitis. Rom J Gastroenterol. 2003;12:107–12.PubMed Gheorghe C, Gheorghe L, Iacob R, et al. Argon plasma coagulation for radiation proctitis. Rom J Gastroenterol. 2003;12:107–12.PubMed
44.
Zurück zum Zitat Ravizza D, Fiori G, Trovato C, et al. Frequency and outcomes of rectal ulcers during argon plasma coagulation for chronic radiation-induced proctopathy. Gastrointest Endosc. 2003;57:519–25.PubMedCrossRef Ravizza D, Fiori G, Trovato C, et al. Frequency and outcomes of rectal ulcers during argon plasma coagulation for chronic radiation-induced proctopathy. Gastrointest Endosc. 2003;57:519–25.PubMedCrossRef
45.
Zurück zum Zitat Swan MP, Moore GT, Sievert W, et al. Efficacy and safety of single-session argon plasma coagulation in the management of chronic radiation proctitis. Gastrointest Endosc. 2010;72:150–4.PubMedCrossRef Swan MP, Moore GT, Sievert W, et al. Efficacy and safety of single-session argon plasma coagulation in the management of chronic radiation proctitis. Gastrointest Endosc. 2010;72:150–4.PubMedCrossRef
46.
Zurück zum Zitat Villavicencio RT, Rex DK, Rahmani E. Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy. Gastrointest Endosc. 2002;55:70–4.PubMedCrossRef Villavicencio RT, Rex DK, Rahmani E. Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy. Gastrointest Endosc. 2002;55:70–4.PubMedCrossRef
47.
Zurück zum Zitat Karamanolis G, Triantafyllou K, Tsiamoulos Z, et al. Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis. Endoscopy. 2009;41:529–31.PubMedCrossRef Karamanolis G, Triantafyllou K, Tsiamoulos Z, et al. Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis. Endoscopy. 2009;41:529–31.PubMedCrossRef
48.
Zurück zum Zitat Ben-Soussan E, Antonietti M, Savoye G, et al. Argon plasma coagulation in the treatment of hemorrhagic radiation proctitis is efficient but requires a perfect colonic cleansing to be safe. Eur J Gastroenterol Hepatol. 2004;16:1315–8.PubMedCrossRef Ben-Soussan E, Antonietti M, Savoye G, et al. Argon plasma coagulation in the treatment of hemorrhagic radiation proctitis is efficient but requires a perfect colonic cleansing to be safe. Eur J Gastroenterol Hepatol. 2004;16:1315–8.PubMedCrossRef
49.
Zurück zum Zitat Alfadhli AA, Alazmi WM, Ponich T, et al. Efficacy of argon plasma coagulation compared to topical formalin application for chronic radiation proctopathy. Can J Gastroenterol. 2008;22:129–32.PubMed Alfadhli AA, Alazmi WM, Ponich T, et al. Efficacy of argon plasma coagulation compared to topical formalin application for chronic radiation proctopathy. Can J Gastroenterol. 2008;22:129–32.PubMed
50.
Zurück zum Zitat Musunuri AS, Prabhakar B, Rao PK, et al. Topical formalin vs argon plasma coagulation for radiation proctitis-experience of a tertiary referral hospital in South India. Gastrointest Endosc. 2006;63:AB79–AB205.CrossRef Musunuri AS, Prabhakar B, Rao PK, et al. Topical formalin vs argon plasma coagulation for radiation proctitis-experience of a tertiary referral hospital in South India. Gastrointest Endosc. 2006;63:AB79–AB205.CrossRef
51.
Zurück zum Zitat Tam WCE, Moore J, Conroy-Hiller TA, et al. Prospective randomised treatmnent trial of argon plasma coagulation and topical formalin for radiation proctitis. Gastrointest Endosc. 2001;53:AB1-240. AB184. Tam WCE, Moore J, Conroy-Hiller TA, et al. Prospective randomised treatmnent trial of argon plasma coagulation and topical formalin for radiation proctitis. Gastrointest Endosc. 2001;53:AB1-240. AB184.
52.
Zurück zum Zitat Denton AS, Bentzen SM, Maher EJ. How useful are observational reports in the evaluation of interventions for radiation morbidity?: an analysis of formalin therapy for late radiation proctitis. Radiother Oncol. 2002;64:291–5.PubMedCrossRef Denton AS, Bentzen SM, Maher EJ. How useful are observational reports in the evaluation of interventions for radiation morbidity?: an analysis of formalin therapy for late radiation proctitis. Radiother Oncol. 2002;64:291–5.PubMedCrossRef
53.
Zurück zum Zitat Zhou C, Adler DC, Becker L, et al. Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol. 2009;2:149–56.PubMedCrossRef Zhou C, Adler DC, Becker L, et al. Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol. 2009;2:149–56.PubMedCrossRef
54.
Zurück zum Zitat Nikfarjam M, Faulx A, Laughinghouse M, et al. Feasibility of radiofrequency ablation for the treatment of chronic radiation proctitis. Surg Innov. 2010;17:92–4.PubMed Nikfarjam M, Faulx A, Laughinghouse M, et al. Feasibility of radiofrequency ablation for the treatment of chronic radiation proctitis. Surg Innov. 2010;17:92–4.PubMed
55.
Zurück zum Zitat Kantsevoy SV, Cruz-Correa MR, Vaughn CA, et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc. 2003;57:403–6.PubMedCrossRef Kantsevoy SV, Cruz-Correa MR, Vaughn CA, et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc. 2003;57:403–6.PubMedCrossRef
56.
Zurück zum Zitat Pasricha PJ, Hill S, Wadwa KS, et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc. 1999;49:627–31.PubMedCrossRef Pasricha PJ, Hill S, Wadwa KS, et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc. 1999;49:627–31.PubMedCrossRef
57.
Zurück zum Zitat Hou JK, Abudayyeh S, Shaib Y. Treatment of chronic radiation proctitis with cryoablation. Gastrointest Endosc. 2011;73:383–9.PubMedCrossRef Hou JK, Abudayyeh S, Shaib Y. Treatment of chronic radiation proctitis with cryoablation. Gastrointest Endosc. 2011;73:383–9.PubMedCrossRef
58.
Zurück zum Zitat Mangiavillano B, Morandi E, Viaggi P, et al. Rectal band ligation for treatment of extensive chronic hemorrhagic radiation proctitis. Endoscopy. 2012;44(Suppl 2 UCTN):E375.PubMed Mangiavillano B, Morandi E, Viaggi P, et al. Rectal band ligation for treatment of extensive chronic hemorrhagic radiation proctitis. Endoscopy. 2012;44(Suppl 2 UCTN):E375.PubMed
59.
Zurück zum Zitat Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29:4–30.PubMed Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002;29:4–30.PubMed
60.
Zurück zum Zitat •• Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72:134–43. This high-quality study shows the beneficial role of hyperbaric oxygen treatment in the management of radiation-induced side effects. PubMedCrossRef •• Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72:134–43. This high-quality study shows the beneficial role of hyperbaric oxygen treatment in the management of radiation-induced side effects. PubMedCrossRef
61.
Zurück zum Zitat Plafki C, Peters P, Almeling M, et al. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71:119–24.PubMed Plafki C, Peters P, Almeling M, et al. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71:119–24.PubMed
Metadaten
Titel
Management of Radiation-Induced Rectal Bleeding
verfasst von
Liboria Laterza
Paolo Cecinato
Alessandra Guido
Alessandro Mussetto
Lorenzo Fuccio
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 11/2013
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-013-0355-z

Weitere Artikel der Ausgabe 11/2013

Current Gastroenterology Reports 11/2013 Zur Ausgabe

Pancreas / Biliary Tract (O Haluszka, Section Editor)

Prevention of Post-ERCP Pancreatitis

Large Intestine (B Cash, Section Editor)

FIT Testing: An Overview

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.